3M 3M Wins USDA Food Safety Testing Contract The USDA Food Safety and Inspection Service will use the company's 3M Molecular Detection System for pathogen detection. New Products Posted to GenomeWeb: Color, 3M, MDNA, More 3M Listeria Assay Approved by Health Canada The test is the first to be approved for the company's second-generation molecular detection system, but can also be run using the first-generation system alongside other existing assays. Bruker Expands License Agreement with 3M for Tissuetyper Tech Bruker said the new agreement would allow it to develop the platform for use in pathology labs, including building clinically validated content libraries. In Brief This Week: Pacific Biosciences; Epigenomics; Cynvenio Biosystems; and More Pacific Biosciences announced this week that it has reached the final developmental milestone of its commercialization and licensing agreement with Roche. Sep 4, 2015 3M Lands AOAC Validation for Listeria Assay Sep 16, 2014 IP Watch: Micronics, Hologic, 3M, Cellular Research Others Win US Patents Premium Jun 5, 2014 Applied Markets Watch: 3M Salmonella Assay Premium Jun 4, 2013 Bruker Inks Patent License Deal with 3M for Technology Related to MALDI Imaging of FFPE Tissue May 8, 2013 IP Watch: UKMRC, Fujifilm, Life Techologies, 3M, Others Win US Patents Premium Apr 18, 2013 Lumora-FIND Malaria Screening Test May be Tip of Iceberg in MDx Development Partnership Premium Mar 14, 2013 PCR Probe Licensing Pact with Focus Diagnostics Portends 'Busy Year' for Evogen Premium Feb 7, 2013 Applied Market Watch: Affymetrix, DNA Link Human ID Pact; Promega PowerPlex Y23; 3M Food Safety Premium Dec 13, 2012 Applied Markets Watch: 3M Molecular Detection Assay Salmonella Premium Nov 29, 2012 IP Watch: PrimeraDx, Hologic, Life Tech, Agilent, Luminex, 3M, Canon, Others Win US Patents Premium Oct 11, 2012 Dx Focus: Focus Diagnostics' Simplexa Flu A/B & RSV Test Premium Oct 9, 2012 FDA Clears Focus Diagnostics' Flu Test on 3M Integrated Cycler Oct 3, 2012 Response Biomedical Regains Rights to Flu, RSV Tests after Termination of 3M Deal Jul 26, 2012 Applied Markets News: Qiagen, 3M Tests AOAC Certified; Life Tech's STEC Testing Workflow Premium May 2, 2012 Applied Markets News: IntegenX, Life Technologies, 3M Food Safety, and Neogen Premium Feb 14, 2012 IP Update: Affymetrix; Gamida for Life; University of Maryland; 3M Premium Dec 15, 2011 Product Watch: 3M Molecular Detection System for Food Safety; Bioline DNA/RNA Extraction Controls Premium Sep 1, 2011 3M to Use Lumora Real-Time Bioluminescent Assay Tech in Food Testing Premium Aug 31, 2011 3M Developing Nucleic Acid Test Kits with Lumora's BART Technology May 12, 2011 IP Watch: Recent Patents Related to PCR, Nucleic Acid Amplification, and Sample Prep: May 12, 2011 Premium Load More Breaking News Compact Gene Editing Enzyme May Improve Success Rates of Gene Therapies People in the News at Veracyte, Invitae, Mount Sinai, InterVenn Biosciences, Applied BioCode, More New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More FDA Releases Proposed Rule for Oversight of Laboratory-Developed Tests CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.